Trial Profile
A phase I study of ERY-ADI
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 29 Aug 2023
Price :
$35
*
At a glance
- Drugs ERY ADI (Primary)
- Indications Cancer
- Focus Adverse reactions
- 25 Sep 2015 New trial record